Sunday, November 17, 2024
HomeIndustriesHealthcare

Healthcare

Canadian Hospital Specialties Limited Invests in Ontario-Based Manufacturing

Canadian Hospital Specialties Limited (CHS) completed the acquisitions of Stadco Polyproducts Inc. ("Stadco") and Respan Products Inc. ("Respan") effective June 3rd 2022. These acquisitions...

SoniVie Announces Successful Procedure With TIVUS System on First Patient Enrolled For REDUCED1 Pilot study

SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS™) System to treat a variety of hypertensive disorders, announced that on May...

Bridge Biotherapeutics to Present Interim Clinical Data from Ongoing Phase 1 Study of BBT-176

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company focused on developing novel drugs for cancer, fibrosis and inflammation, announced that interim clinical data...

Turn Therapeutics Announces Positive In-Vivo Data for Non-Melanoma Skin Cancer Candidate

Turn Therapeutics, a biotechnology company developing innovative products for infectious disease, advanced wound care, and dermatology, announced positive in-vivo data for its therapeutic candidate...

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer’s Disease

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimer's disease mouse model (aged APP/PS1+/-...
0FansLike
0FollowersFollow
spot_img

Hot Topics